Literature DB >> 9378235

The pharmacology of the antioxidant lipoic acid.

G P Biewenga1, G R Haenen, A Bast.   

Abstract

1. Lipoic acid is an example of an existing drug whose therapeutic effect has been related to its antioxidant activity. 2. Antioxidant activity is a relative concept: it depends on the kind of oxidative stress and the kind of oxidizable substrate (e.g., DNA, lipid, protein). 3. In vitro, the final antioxidant activity of lipoic acid is determined by its concentration and by its antioxidant properties. Four antioxidant properties of lipoic acid have been studied: its metal chelating capacity, its ability to scavenge reactive oxygen species (ROS), its ability to regenerate endogenous antioxidants and its ability to repair oxidative damage. 4. Dihydrolipoic acid (DHLA), formed by reduction of lipoic acid, has more antioxidant properties than does lipoic acid. Both DHLA and lipoic acid have metal-chelating capacity and scavenge ROS, whereas only DHLA is able to regenerate endogenous antioxidants and to repair oxidative damage. 5. As a metal chelator, lipoic acid was shown to provide antioxidant activity by chelating Fe2+ and Cu2+; DHLA can do so by chelating Cd2+. 6. As scavengers of ROS, lipoic acid and DHLA display antioxidant activity in most experiments, whereas, in particular cases, pro-oxidant activity has been observed. However, lipoic acid can act as an antioxidant against the pro-oxidant activity produced by DHLA. 7. DHLA has the capacity to regenerate the endogenous antioxidants vitamin E, vitamin C and glutathione. 8. DHLA can provide peptide methionine sulfoxide reductase with reducing equivalents. This enhances the repair of oxidatively damaged proteins such as alpha-1 antiprotease. 9. Through the lipoamide dehydrogenase-dependent reduction of lipoic acid, the cell can draw on its NADH pool for antioxidant activity additionally to its NADPH pool, which is usually consumed during oxidative stress. 10. Within drug-related antioxidant pharmacology, lipoic acid is a model compound that enhances understanding of the mode of action of antioxidants in drug therapy.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9378235     DOI: 10.1016/s0306-3623(96)00474-0

Source DB:  PubMed          Journal:  Gen Pharmacol        ISSN: 0306-3623


  146 in total

1.  Differential effects of coenzyme Q10 and α-lipoic acid on two models of in vitro oxidative damage to the rabbit urinary bladder.

Authors:  Hsin T Li; Catherine Schuler; Robert E Leggett; Robert M Levin
Journal:  Int Urol Nephrol       Date:  2010-06-08       Impact factor: 2.370

Review 2.  Complementary and alternative medicine: is there a role in multiple sclerosis?

Authors:  Vijayshree Yadav; Dennis Bourdette
Journal:  Curr Neurol Neurosci Rep       Date:  2006-05       Impact factor: 5.081

3.  Quantum-chemical investigation of the structure and the antioxidant properties of α-lipoic acid and its metabolites.

Authors:  Małgorzata Szeląg; Damian Mikulski; Marcin Molski
Journal:  J Mol Model       Date:  2011-11-30       Impact factor: 1.810

4.  Alpha-lipoic acid preserves the structural and functional integrity of red blood cells by adjusting the redox disturbance and decreasing O-GlcNAc modifications of antioxidant enzymes and heat shock proteins in diabetic rats.

Authors:  Mihailović Mirjana; Arambašić Jelena; Uskoković Aleksandra; Dinić Svetlana; Grdović Nevena; Marković Jelena; Poznanović Goran; Vidaković Melita
Journal:  Eur J Nutr       Date:  2011-11-18       Impact factor: 5.614

5.  Complementary and alternative medicine for the treatment of multiple sclerosis.

Authors:  Vijayshree Yadav; Lynne Shinto; Dennis Bourdette
Journal:  Expert Rev Clin Immunol       Date:  2010-05       Impact factor: 4.473

Review 6.  Reactive oxygen species in the regulation of synaptic plasticity and memory.

Authors:  Cynthia A Massaad; Eric Klann
Journal:  Antioxid Redox Signal       Date:  2010-10-28       Impact factor: 8.401

7.  Lipoic acid improves hypertriglyceridemia by stimulating triacylglycerol clearance and downregulating liver triacylglycerol secretion.

Authors:  Judy A Butler; Tory M Hagen; Régis Moreau
Journal:  Arch Biochem Biophys       Date:  2009-02-20       Impact factor: 4.013

Review 8.  Lipoic Acid and Other Antioxidants as Therapies for Multiple Sclerosis.

Authors:  Carin Waslo; Dennis Bourdette; Nora Gray; Kirsten Wright; Rebecca Spain
Journal:  Curr Treat Options Neurol       Date:  2019-05-06       Impact factor: 3.598

9.  Alpha-lipoic acid and ebselen prevent ischemia/reperfusion injury in the rat intestine.

Authors:  Ahmet Guven; Turan Tunc; Turgut Topal; Mustafa Kul; Ahmet Korkmaz; Gokhan Gundogdu; Onder Onguru; Haluk Ozturk
Journal:  Surg Today       Date:  2008-10-29       Impact factor: 2.549

10.  A key role for lipoic acid synthesis during Plasmodium liver stage development.

Authors:  Brie Falkard; T R Santha Kumar; Leonie-Sophie Hecht; Krista A Matthews; Philipp P Henrich; Sonia Gulati; Rebecca E Lewis; Micah J Manary; Elizabeth A Winzeler; Photini Sinnis; Sean T Prigge; Volker Heussler; Christina Deschermeier; David Fidock
Journal:  Cell Microbiol       Date:  2013-04-05       Impact factor: 3.715

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.